Tykerb Interactions
There are 636 drugs known to interact with Tykerb (lapatinib), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 123 are major, 500 are moderate, and 13 are minor.
- View all 636 medications that may interact with Tykerb
- View Tykerb alcohol/food interactions (2)
- View Tykerb disease interactions (9)
Most frequently checked interactions
View interaction reports for Tykerb (lapatinib) and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Afinitor (everolimus)
- allopurinol
- Ativan (lorazepam)
- Avastin (bevacizumab)
- biotin
- Calcium 600 D (calcium / vitamin d)
- calcium citrate
- calcium / vitamin d
- capecitabine
- carvedilol
- CoQ10 (ubiquinone)
- cyclobenzaprine
- Cymbalta (duloxetine)
- dexamethasone
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- Herceptin (trastuzumab)
- Keppra (levetiracetam)
- letrozole
- lorazepam
- Nexium (esomeprazole)
- ondansetron
- prochlorperazine
- venlafaxine
- Vitamin D3 (cholecalciferol)
- Xeloda (capecitabine)
- Xgeva (denosumab)
- Zometa (zoledronic acid)
- Zyrtec (cetirizine)
Tykerb alcohol/food interactions
There are 2 alcohol/food interactions with Tykerb (lapatinib).
Tykerb disease interactions
There are 9 disease interactions with Tykerb (lapatinib) which include:
- cardiomyopathy
- dermatologic toxicities
- pulmonary toxicity
- QT prolongation
- pulmonary toxicity
- liver dysfunction
- CHF
- thrombocytopenia
- renal impairment
Report options
QR code containing a link to this page
More about Tykerb (lapatinib)
- Tykerb consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
